Published in Mol Cell Biol on June 01, 2006
PP2A regulates HDAC4 nuclear import. Mol Biol Cell (2007) 1.34
Shugoshin prevents cohesin cleavage by PP2A(Cdc55)-dependent inhibition of separase. Genes Dev (2009) 1.08
Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling. Oncogene (2011) 1.01
Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein F. J Cell Sci (2010) 1.01
A specific form of phospho protein phosphatase 2 regulates anaphase-promoting complex/cyclosome association with spindle poles. Mol Biol Cell (2010) 0.98
Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells. J Biol Chem (2007) 0.94
PP2A delays APC/C-dependent degradation of separase-associated but not free securin. EMBO J (2014) 0.90
PP2A as a master regulator of the cell cycle. Crit Rev Biochem Mol Biol (2016) 0.85
Glycogen synthase kinase-3beta (GSK3beta) negatively regulates PTTG1/human securin protein stability, and GSK3beta inactivation correlates with securin accumulation in breast tumors. J Biol Chem (2011) 0.84
Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells. Breast Cancer Res (2012) 0.82
Plasmin overcomes resistance to prostaglandin E2 in fibrotic lung fibroblasts by reorganizing protein kinase A signaling. J Biol Chem (2011) 0.81
Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A. Mol Cell Biol (2008) 0.79
SCF(FBXW7α) modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability. Oncotarget (2014) 0.78
Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells. PLoS One (2012) 0.77
Methylation alterations are not a major cause of PTTG1 misregulation. BMC Cancer (2008) 0.77
Protein Phosphatases Involved in Regulating Mitosis: Facts and Hypotheses. Mol Cells (2016) 0.75
βTrCP controls the lysosome-mediated degradation of CDK1, whose accumulation correlates with tumor malignancy. Oncotarget (2014) 0.75
A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21
Genetic instabilities in human cancers. Nature (1998) 22.76
Cyclin is degraded by the ubiquitin pathway. Nature (1991) 17.93
The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci U S A (1991) 15.52
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87
Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p. Genes Dev (1996) 8.28
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61
Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci (1990) 6.45
The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev (2000) 6.43
Regulation of the yeast HO gene. Cold Spring Harb Symp Quant Biol (1985) 6.27
The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol Cell (2002) 6.26
Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science (1999) 6.07
Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell (2000) 5.69
An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast. Cell (1998) 5.29
Segregating sister genomes: the molecular biology of chromosome separation. Science (2002) 4.92
Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet (1998) 4.90
Cut2 proteolysis required for sister-chromatid seperation in fission yeast. Nature (1996) 4.86
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol (2000) 4.53
Dual inhibition of sister chromatid separation at metaphase. Cell (2001) 4.23
Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell (1998) 4.21
Securin is required for chromosomal stability in human cells. Cell (2001) 3.71
A family of mammalian F-box proteins. Curr Biol (1999) 3.68
Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell (1999) 3.58
Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature (2003) 3.54
How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell (1999) 3.34
Identification of a family of human F-box proteins. Curr Biol (1999) 3.31
Pds1p is required for faithful execution of anaphase in the yeast, Saccharomyces cerevisiae. J Cell Biol (1996) 2.98
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol (2000) 2.96
Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol (1997) 2.90
SCF and APC: the Yin and Yang of cell cycle regulated proteolysis. Curr Opin Cell Biol (1998) 2.71
Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet (1993) 2.47
Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet (2000) 2.39
Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet (2002) 2.32
Fission yeast Cut1 and Cut2 are essential for sister chromatid separation, concentrate along the metaphase spindle and form large complexes. EMBO J (1996) 2.23
Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis. EMBO J (2001) 2.08
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene (1994) 2.05
Dual mode of degradation of Cdc25 A phosphatase. EMBO J (2002) 1.95
Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol (1999) 1.78
Mutual inhibition of separase and Cdk1 by two-step complex formation. Mol Cell (2005) 1.72
The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation. Mol Cell Biol (2000) 1.67
Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene (2004) 1.66
Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol Endocrinol (2001) 1.61
hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene (1998) 1.57
Separation of sister chromatids in mitosis requires the Drosophila pimples product, a protein degraded after the metaphase/anaphase transition. Cell (1996) 1.55
The dual mechanism of separase regulation by securin. Curr Biol (2002) 1.39
Protein phosphatase 2A: who shall regulate the regulator? Biochem Pharmacol (1999) 1.36
hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene (1999) 1.34
Degradation of Drosophila PIM regulates sister chromatid separation during mitosis. Genes Dev (2000) 1.28
Two conserved domains in regulatory B subunits mediate binding to the A subunit of protein phosphatase 2A. Eur J Biochem (2002) 1.28
Phosphorylation of the mitotic regulator Pds1/securin by Cdc28 is required for efficient nuclear localization of Esp1/separase. Genes Dev (2002) 1.27
Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Res (2001) 1.19
A phosphorylation-driven ubiquitination switch for cell-cycle control. Trends Cell Biol (2002) 1.14
Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene (2000) 1.14
Vav binding to heterogeneous nuclear ribonucleoprotein (hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner. J Biol Chem (1998) 0.98
Molecular cloning and characterization of the tumor transforming gene (TUTR1): a novel gene in human tumorigenesis. Cytogenet Cell Genet (1999) 0.97
Expression of hpttg proto-oncogene in lymphoid neoplasias. Oncogene (2002) 0.90
Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem (2002) 0.90
Securin is a target of the UV response pathway in mammalian cells. Mol Cell Biol (2004) 0.89
Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet (2002) 2.32
Defining the CT angiography 'spot sign' in primary intracerebral hemorrhage. Can J Neurol Sci (2009) 1.28
Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke (2006) 1.17
IB-00208, a new cytotoxic polycyclic xanthone produced by a marine-derived Actinomadura. I. Isolation of the strain, taxonomy and biological activites. J Antibiot (Tokyo) (2003) 0.94
Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage. Stroke (2011) 0.90
Expression of hpttg proto-oncogene in lymphoid neoplasias. Oncogene (2002) 0.90
Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin. PLoS One (2012) 0.90
Securin is a target of the UV response pathway in mammalian cells. Mol Cell Biol (2004) 0.89
Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer. J Clin Endocrinol Metab (2006) 0.89
UV-induced degradation of securin is mediated by SKP1-CUL1-beta TrCP E3 ubiquitin ligase. J Cell Sci (2008) 0.88
Glycogen synthase kinase-3beta (GSK3beta) negatively regulates PTTG1/human securin protein stability, and GSK3beta inactivation correlates with securin accumulation in breast tumors. J Biol Chem (2011) 0.84
The effect of FITA mutations on the symbiotic properties of Sinorhizobium fredii varies in a chromosomal-background-dependent manner. Arch Microbiol (2003) 0.83
A single mutation in Securin induces chromosomal instability and enhances cell invasion. Eur J Cancer (2012) 0.83
Web-based adaptive training simulator system for cardiac life support. Artif Intell Med (2006) 0.82
Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway. J Proteomics (2012) 0.82
Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'. Appl Microbiol Biotechnol (2012) 0.80
The effect of omalizumab on small airway inflammation as measured by exhaled nitric oxide in moderate-to-severe asthmatic patients. Allergy Asthma Proc (2014) 0.80
Dyspnea and obesity in African American women. Ann Allergy Asthma Immunol (2008) 0.77
Immunomodulation by Yersinia enterocolitica: comparison of live and heat-killed bacteria. FEMS Immunol Med Microbiol (2003) 0.76
Streptomyces tacrolimicus sp. nov., a low producer of the immunosuppressant tacrolimus (FK506). Int J Syst Evol Microbiol (2010) 0.76
[Renal angiomyolipoma with arteriovenous fistula causing retroperitoneal hematoma. Case report]. Arch Esp Urol (2004) 0.75